This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FLEXISEQ® Wins BVDA Innovation Of 2013 Award: Innovative New Treatment For The Symptoms Of Osteoarthritis

FRANKFURT, Germany and LONDON, February 4, 2013 /PRNewswire/ --

The Federal Association of German Pharmacists (BVDA)  today presented its "Innovation Award 2013" to FLEXISEQ®, an innovative new treatment for pain and stiffness associated with osteoarthritis (OA).

The BVDA president, and pharmacist Thomas Hieble, explained; "The jury awarded the prize to FLEXISEQ® in recognition of the application of its innovative Sequessome Technology® to deliver symptom relief to sufferers of OA. The technology incorporates highly flexible phospholipid vesicles which can penetrate the skin and into the affected joint below. Once inside the joint, they accumulate on the surface of the cartilage to lubricate it. The result: pain relief and increased joint mobility - achieved conveniently and without the risk of the well recognised, systemic side effects associated with drugs typically used for the treatment of OA."

In their latest editions, various renowned medical journals such as "Ärzte Zeitung" and the "Zeitschrift für Rheumatologie" reported on this medical advance.

FLEXISEQ has an innovative mode of action due to its use of Sequessome Technology and its convenient gel formulation enables patients to self administer FLEXISEQ topically to the affected joint. The Sequessome™ vesicles contained within are proven to enter the synovial joint after application and increase phospholipid levels in the synovial fluid where they are known to be depleted in joints affected by OA. This physical, mode of action reduces the pain, (in phase III clinical trials, as effectively as the frequently prescribed oral drug medicine - celecoxib) and also improves joint mobility, thereby giving easier movement to patients.

Hundreds of millions of people worldwide suffer from OA, a chronic joint disease which makes the lives of those affected permanently more difficult. According to the Robert Koch Institute, the likelihood of contracting OA increases dramatically with age.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,195.42 +221.11 1.30%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,566.1380 +16.9120 0.37%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs